- Home
- AAPG vs GOF Comparison
AAPG vs GOF Comparison
Compare AAPG & GOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AAPG | GOF |
|---|---|---|
| Founded | 2009 | 2006 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.3B |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | AAPG | GOF |
|---|---|---|
| Price | $30.00 | $12.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $48.50 | N/A |
| AVG Volume (30 Days) | 5.1K | ★ 789.2K |
| Earning Date | 11-19-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 15.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $54,524,554.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $368.64 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $16.50 | $10.96 |
| 52 Week High | $48.45 | $16.76 |
Technical Indicators
Market Signals| Indicator | AAPG | GOF |
|---|---|---|
| Relative Strength Index (RSI) | 50.39 | 33.22 |
| Support Level | $30.00 | $11.87 |
| Resistance Level | $33.09 | $12.50 |
| Average True Range (ATR) | 0.83 | 0.23 |
| MACD | 0.14 | 0.04 |
| Stochastic Oscillator | 72.07 | 21.43 |
Price Performance
Historical ComparisonAbout AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies. The company's geographical segments include the United States and Mainland China.
About GOF Guggenheim Strategic Opportunities Fund of Beneficial Interest
Guggenheim Strategic Opportunities Fund is a diversified, closed-end management investment company. The investment objective of the firm is to maximize total return through a combination of current income and capital appreciation. The Fund seeks to combine a credit-managed fixed-income portfolio with access to a diversified pool of alternative investments and equity strategies.